Quantcast

Latest Multiple drug resistance Stories

2009-03-27 09:49:18

A research team at the Scripps Research Institute has obtained the first glimpse of a protein that keeps certain substances, including many drugs, out of cells. The protein, called P-glycoprotein or P-gp for short, is one of the main reasons cancer cells are resistant to chemotherapy drugs. Understanding its structure may help scientists design more effective drugs. The new research was described in the March 27, 2009, issue of the journal Science. "This structure is an important advance and...

2009-03-26 03:30:00

PARIS, March 26 /PRNewswire-FirstCall/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today the appointment of Dr. Karen Bush to the Company's Scientific Advisory Board (SAB). Novexel's SAB is chaired by Dr. David Shlaes who sits on the Company's board. Dr. Bush, who is currently Adjunct Professor at the Department of Biology at Indiana...

2009-03-17 10:48:00

WASHINGTON, March 17 /PRNewswire-USNewswire/ -- Keep Antibiotics Working (KAW) -- a national coalition of health, consumer, agricultural, environmental, humane, and other advocacy groups with more than ten million supporters -- today welcomed the reintroduction of a bill that would help combat the antibiotic resistance crisis by targeting the overuse of antibiotics important to human medicine in animal agriculture. The legislation, "The Preservation of Antibiotics for Medical Treatment...

2009-03-04 06:00:00

Product Candidate NVC-422 Demonstrates Ability to Treat Subcutaneous Infections EMERYVILLE, Calif., March 4 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY), a clinical stage biopharmaceutical company, today announced that new preclinical data related to NVC-422, the lead molecule in NovaBay's, proprietary Aganocide(R) class of compounds, will be presented at the American Academy of Dermatology (AAD) 67th Annual Meeting in San Francisco during March 6-10, 2009....

2009-02-10 07:30:00

SAN DIEGO, Feb. 10 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital. Other participating investors include RiverVest Venture Partners, as well as existing investors SV Life Sciences, HBM BioVentures, Aberdare Ventures and Adams Street Partners. These investors have made commitments to additional closings that could bring the total Series D financing to $40.0 million. Mpex's...

2009-01-08 18:29:00

BOSTON, Jan. 8 /PRNewswire-USNewswire/ -- The Alliance for the Prudent Use of Antibiotics (APUA) strongly opposes the new marketing campaigns by Wal-Mart, Stop and Shop, Publix, and other large chains, to provide free prescribed antibiotics to customers. These offers are portrayed as cost-saving but they will actually lead to increased costs in the form of treatment failures because of antibiotic resistance. While the public's need for affordable healthcare is indisputable, providing free...

2008-12-18 10:01:13

Case Western Reserve University School of Medicine scientist leads comparative analysis of six genomes of Acinetobacter baumanniiThe recent emergence of multidrug resistance (MDR) in Acinetobacter baumannii, a bacteria that causes infections primarily among seriously ill patients in the intensive care unit who may have reduced immune systems, has raised concern in health care settings worldwide. When comparing the genome sequence of three MDR A. baumannii isolates and three drug-susceptible...

2008-11-06 09:00:44

Accelr8 Technology Corporation (Amex: AXK) announced study results today that were presented at the joint sessions of the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC, www.icaac.org) and the Infectious Diseases Society of America (IDSA, www.idsociety.org), October 25-29 in Washington, DC. The purpose of the study was to characterize a rapid test run on Accelr8's BACcel(TM) diagnostic system to detect a broad multiple antibiotic resistance mechanism known...

2008-11-03 18:00:20

NEW HAVEN, Conn., Nov. 3 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced today that Susan Froshauer, PhD, President and Chief Executive Officer, is scheduled to present at the Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008 at 2:00pm EST. The conference will be held from November...

2008-10-28 12:00:39

HELSINKI, October 28 /PRNewswire/ -- Northern Antibiotics Ltd., the developer of novel polymyxin derivatives for the treatment of infections caused by multidrug-resistant Gram-negative bacteria, revealed today animal efficacy and pharmacokinetic data from their NAB compounds at the 48th Annual ICAAC/IDSA 46th Annual Meeting in Washington, DC. Northern Antibiotics has developed two series of novel polymyxin (NAB) compounds (Vaara M. et al., 2008, Antimicrob. Agents Chemother. 52:3229). The...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related